Your browser doesn't support javascript.
loading
VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells.
Cruvinel, Wilson de Melo; Andrade, Luis Eduardo Coelho; Dellavance, Alessandra; Ximenes, Antônio Carlos; Bichara, Carlos David Araújo; Mangueira, Cristóvão Luis Pitangueira; Bonfá, Eloísa; de Almeida Brito, Fabiano; Mariz, Henrique Ataíde; Dos Anjos, Lisiane Maria Enriconi; Pasoto, Sandra Gofinet; Valim, Valeria; Dos Santos, Wilton Ferreira Silva; Gomes, Clayson Moura; Neves, Roberpaulo Anacleto; Francescantonio, Paulo Luiz Carvalho.
Afiliação
  • Cruvinel WM; School of Medical and Life Sciences, Escola de Ciências Médicas e da Vida, Pontifícia Universidade Católica de Goiás (PUC GOIÁS), Avenida Universitária 1.440, Setor Universitário, Goiânia, GO, 74605-010, Brazil. melocruvinel@gmail.com.
  • Andrade LEC; Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
  • Dellavance A; Immunology Division, Fleury Medicine and Health Laboratories, São Paulo, Brazil.
  • Ximenes AC; Divisão de Pesquisa, Inovação e Desenvolvimento, Fleury Medicina E Saúde, São Paulo, SP, Brazil.
  • Bichara CDA; Hospital Geral de Goiânia Alberto Rassi, Goiânia, GO, Brazil.
  • Mangueira CLP; Centro Universitário Metropolitano da Amazônia (UNIFAMAZ), Amaral Costa Medicina Diagnóstica, Belém, PA, Brazil.
  • Bonfá E; Departamento de Patologia Clínica e Anatomia Patológica, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • de Almeida Brito F; Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil.
  • Mariz HA; Department of Clinical Pathology, School of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
  • Dos Anjos LME; Hermes Pardini Group, Vespasiano, MG, Brazil.
  • Pasoto SG; Rheumatology Department, Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil.
  • Valim V; Universidade do Sul de Santa Catarina (UNISUL) e Universidade do Vale do Itajaí (UNIVALI), Florianópolis, SC, Brazil.
  • Dos Santos WFS; Serviço de Reumatologia e Laboratório de Autoimunidade da Divisão de Laboratório Central do Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
  • Gomes CM; Universidade Federal do Espírito Santo (UFES), Vitória, ES, Brazil.
  • Neves RA; Escola Superior de Ciências da Saúde do Distrito Federal (ESCS) e Laboratório Sabin, Brasília, DF, Brazil.
  • Francescantonio PLC; School of Medical and Life Sciences, Escola de Ciências Médicas e da Vida, Pontifícia Universidade Católica de Goiás (PUC GOIÁS), Avenida Universitária 1.440, Setor Universitário, Goiânia, GO, 74605-010, Brazil.
Adv Rheumatol ; 62(1): 34, 2022 09 07.
Article em En | MEDLINE | ID: mdl-36071498
ABSTRACT

BACKGROUND:

The VI Brazilian Consensus on Autoantibodies against HEp-2 cells for determination of autoantibodies against cellular constituents on HEp-2 cells was held on September, 2019, in Fortaleza (CE, Brazil). The guidelines in this edition were formulated by the group of Brazilian experts discussing the classification of complex patterns, the classification of the nuclear discrete dots (few and multiple), the identification of the discrete fine speckled pattern (AC-4a) and improvements on the ANA report. MAINBODY Sixteen Brazilian researchers and experts from universities and clinical laboratories representing the various geographical regions of Brazil participated in the meeting. Four main topics were discussed (1) How to classify patterns with fluorescence in more than one cell compartment considering three relevant categoris composite patterns, mixed patterns and multiple patterns; (2) The splitting of the discrete nuclear dots pattern into the multiple discrete nuclear dots (AC-6) and few discrete nuclear dots (AC-7) patterns, respectively; (3) Inclusion of a novel nuclear pattern characterized by discrete fine speckled pattern highly associated with antibodies to SS-A/Ro60, classified as AC-4a. In addition, adjustments on the Brazilian Consensus nomenclature were implemented aiming to harmonize the designation of some patterns with the International Consensus on ANA Patterns (ICAP). Furthermore, the designations of the PCNA-like pattern (AC-13), CENP-F-like pattern (AC-14) and Topo I-like pattern (AC-29) were adjusted in accordance to ICAP. Finally, there was a recommendation for adjustment in the test report in order to address the status of nuclear envelope staining. For all topics, the aim was to establish specific guidelines for laboratories and clinicians. All recommendations were based on consensus among participants. All recommendations from the V Consensus were maintained and there was relevant progress in the BCA/HEp-2 guidelines and further harmonization with ICAP.

CONCLUSION:

The VI BCA/HEp-2 edition was successful in establishing important recommendations regarding the classification of complex patterns, in supporting the identification of a novel pattern within the AC-4 group and in the harmonization process with the ICAP terminology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Anticorpos Antinucleares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Anticorpos Antinucleares Idioma: En Ano de publicação: 2022 Tipo de documento: Article